Once cognate T cells and B cells have been activated by antigen during an immune response to a pathogen, IL-6 is thought to drive TFH cell differentiation and IL-21 secretion (Fazilleau et al., 2009; King, 2009). IL-6 production in follicular B cells in the draining lymph node was an important early event during the antiviral response and that B cellCderived IL-6 was necessary and sufficient to induce IL-21 from CD4+ T cells in vitro and to support TFH cell development in vivo. Finally, the transcriptional activator Oct2 and its cofactor OBF-1 were identified as regulators of expression in B cells. Protective long-term humoral immunity against pathogens depends on ADU-S100 (MIW815) the generation of antibodies of high affinity that are capable of appropriate effector functions, a process which relies on the formation of germinal centers (GCs) in LNs or in the spleen during contamination. GCs are essential but transient structures in which high affinity antibody-secreting cells and memory B cells are generated during a T cellCdependent (TD) antibody response. Although B cells constitute the majority of cells within a GC, macrophages, follicular DCs, and CD4+ T cells contribute to the defined architecture and the functionality of a GC during an immune response. These cells cooperate via antigen presentation, adhesion molecules, cell surface co-stimulatory molecules, and secreted factors to enable a strong GC reaction and an effective antibody response. The formation and maintenance of GCs require a specialized subset of CD4+ T cells, T follicular helper cells (TFH cells; Yu and Vinuesa, 2010; Crotty, 2011; Nutt and Tarlinton, 2011). TFH cells that are induced during TD responses are characterized by the expression of several crucial surface markers that interact with ligands on APCs such as DCs and B cells. These molecules include co-stimulatory molecules and their ligands (PD-1, ICOS, CD200, OX40, and CD40-ligand), adhesion mediators of the Slam/SAP family, and receptors for IL-6 and IL-21 (King et al., 2008; Nurieva et al., 2008; Ma et al., 2009; Yusuf et al., 2010). The coordinated induction of the chemokine receptor CXCR5, and repression of CCR7, allows TFH to home to B cell follicles (Ansel et al., 1999; Haynes et al., 2007). CXCR5 induction depends on an OX40-mediated transmission in TFH (Brocker et al., 1999). Antigen-presenting B cells meet their cognate TFH cells at the TCB border and engage in prolonged interactions, mediated by antigen and Slam/SAP proteins, to deliver signals that are essential for TFH maintenance and subsequent productive GC formation (Qi et al., 2008; Deenick et al., 2010). Once in the follicle, TFH cells provide help to activated B cells through the expression of molecules such as CD40-ligand and ICOS ADU-S100 (MIW815) and through the secretion of cytokines, predominantly IL-4 and IL-21 (Chtanova et al., 2004; Reinhardt et al., 2009). IL-21, a pleiotropic cytokine, is usually a hallmark of TFH cells. It has been shown to induce proliferation and expression of and in B cells, thereby influencing their decision to differentiate into antibody-secreting cells or to continue to participate in the GC reaction (Ozaki et al., 2004; Arguni et al., 2006). Furthermore, IL-21 promotes switching to IgG1, IgG2a and IgG3 and inhibits IgE responses (Ozaki et al., ADU-S100 (MIW815) 2002). Recent studies have suggested that both IL-6 and IL-21 have pivotal functions in vivo in the generation of IL-21Csecreting TFH cells and the formation of GCs CD320 (King et al., 2008; Nurieva et al., 2008; Suto et al., 2008). Differentiation of an activated CD4+ T cell into an IL-21Csecreting TFH cell is dependent around the transcription factor Bcl6, which acts as a grasp regulator for CD4+ TFH cell differentiation (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). In vitro, IL-6 and IL-21 are able to stimulate and enhance expression in CD4+ T cells, consistent with these cytokines providing an inductive role for TFH (Suto et al., 2008). Nurieva et al. (2008) reported that mice deficient in IL-6 created fewer GC B cells and have reduced TFH cell figures after an immune challenge with sheep reddish blood cells. Similarly, other groups exhibited a reduced frequency and size of GCs in IL-6Cdeficient mice (Kopf et al., 1998; Wu et al., 2009). In some of the aforementioned studies, the impaired formation of GCs in the IL-6Cdeficient mice was linked to a reduction of IL-21Cgenerating TFH cells (Nurieva et al., 2008;.